0000000000098001

AUTHOR

Domenico Campisi

The profession of doctor in Sicily

research product

Indium-111 Oxine Platelets Survival In Patients Suffering Of Cardiac And Cerebral Arteriosclerosis

research product

Salvaguardia e valorizzazione di razze ovine autoctone siciliane

research product

Antica saggezza contadina e realtà moderna: il vino rosso ed i suoi benefici effetti sulla salute

research product

Relationship between body fat distribution and blood disorders in patients with visceral obesity with and without diabetes mellitus

research product

Sicilian red wines and cardiovascular risk factors: short term and cross over study

research product

Effects of moderate consumption of sicilian red wines on some cardiovascular risk factors

research product

Effetti a lungo termine del trattamento con Simvastatina ed Ezetimibe sui livelli di HDL-C e hs-PCR in pazienti affetti da Ipercolesterolemia familare(FH) con pregresso IMA e/o Lesione carotidea

research product

Effetto di due vini rossi siciliani su alcuni fattori di rischio cardiovascolare

Background. The aim of this study was to evaluate whether Sicilian red wine consumption is associated with a lower cardiovascular risk. Methods. Forty-eight subjects of both sexes (age range 35-65 years) nondrinkers or rarely drinkers of moderate red wine intake were selected. Subjects were divided into two groups (group A and group B), assigned to receive with a crossover design 250 ml/die (during the meals) of one of two types of Sicilian red wines (Nero d’Avola and Etna Torrepalino respectively). At all visits (-15 days, basal, +4 and +8 weeks) the following parameters were measured: blood glucose, total cholesterol and triglycerides (by enzyme kit methods, Boehringer Mannheim, Milan, It…

research product

Efficacia della Atorvastatina E n-3 Pufa in pazienti affetti da dislipidemia combinata e ad alto rischio di eventi cardiovascolari

research product

Efficacia della associazione Atorvastatina e n-3 PUFA in pazienti affetti da dislipidemia combinata e ad alto rischio di eventi cardiovascolari

research product

One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease.

Aim. Statins are the drugs of choice in heterozygous familial hypercholesterolemia (FH), which has a high risk of premature cardiovascular events including myocardial infarction, stroke, and surgical revascularization. Methods. A 1-year open-label study was conducted to test the efficacy and tolerability of Atorvastatin titrated to the target, in proven FH patients and to evaluate certain inflammatory parameters. One hundred and two FH patients (44 men and 58 women; mean age 58.7±3.6 years) were included in the study. After evaluation using the B-mode duplex scanning system of extracranial carotid arteries, the patients were divided into groups: Group 1 (15 men, 25 women) with carotid plaqu…

research product

One year atorvastatin treatment in patients with familial hypercholesterolrmia: effects on CRP and fibrinogen

research product

Il vino : trentamila anni di storia

research product